抗生素抗药性诊断市场：全球 2024-2030 年

全基因定序和多重就地检验的转变正在透过提高速度、准确性和高通量来推动变革性成长。

抗菌药物抗药性是指细菌、病毒和真菌不再对抗生素敏感，是全球十大公共卫生威胁之一。当病原体获得抗药性时，它​​们就会变得无效，并可能导致引发败血症的感染疾病，大大增加严重疾病、残疾和死亡的风险。

本报告研究了人类健康抗菌素抗药性（AMR）诊断市场。它分析表型和分子测试的收益和预测预测、竞争格局，并确定提供 IVD 平台（包括仪器、消耗品和资讯学）的供应商（製造商）。医院、诊所、诊断实验室和其他机构是主要的最终使用者。该报告还提供了北美、欧洲、亚太、中东和非洲以及拉丁美洲的区域预测。透过分析推动和抑制市场成长的因素并识别关键成长机会，我们帮助市场参与者和相关人员利用趋势，最大限度地发挥其经济潜力并维持价值。基准年为2024年，预测期间为2025-2030年。

目录

成长机会：研究范围

• 分析范围
• 分割

成长环境：抗菌药物抗药性诊断市场的转型

• 成长为何变得越来越艰难？
• 策略要务
• 三大策略要务对抗菌药物抗药性诊断产业的影响

AMR 诊断市场生态系统

• 竞争环境
• 主要竞争对手

AMR 诊断市场的成长要素

• 成长指标
• 成长动力
• 成长抑制因素
• 检查预测
• 收益预测
• 产品收益预测
• 各地区收益预测
• 收益预测分析
• 价格趋势及预测分析
• 收益分享
• 竞争矩阵 –产品系列分析
• 收益分布分析

用于表型检测的生长促进要素

• 成长指标
• 收益预测
• 各地区收益预测
• 预测分析

用于分子检测的生长促进要素

• 成长指标
• 收益预测
• 各地区收益预测
• 预测分析

成长机会

• 成长机会1：利用 WGS 推动分子侦测
• 成长机会二：多重 POCT
• 成长机会3：公私合营抗菌药物管理

附录与后续步骤

The Shift to Whole-genome Sequencing and Multiplex Point-of-care Testing is Driving Transformational Growth Due to Improved Speed, Accuracy, and High Throughput

This Frost & Sullivan report examines the antimicrobial resistance (AMR) diagnostics market in human health. AMR, characterized by bacteria, viruses, and fungi that no longer respond to antimicrobial medications, is one of the top ten global public health threats. When pathogens develop drug resistance, medications become ineffective, leading to infections that may trigger sepsis and significantly increase the risk of severe illness, disability, and death. Covering in vitro diagnostics (IVD) methods, this report includes phenotypic and molecular tests for revenue and forecast estimations. It analyzes the competitive environment, identifying vendors (manufacturers) offering IVD platforms, including instruments, consumables, and informatics. Hospitals, clinics, diagnostic labs, and others encompass key end-user verticals.

The analysis offers a region-wise forecast for North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America. The study analyzes the factors driving and restraining the growth of this market and identifies key growth opportunities to help market players and stakeholders build on trends, maximize economic potential, and sustain value. The base year is 2024, and the forecast period is from 2025 to 2030.

Table of Contents

Growth Opportunities: Research Scope

• Scope of Analysis
• Segmentation

Growth Environment: Transformation in the AMR Diagnostics Market

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the AMR Diagnostics Industry

Ecosystem in the AMR Diagnostics Market

• Competitive Environment
• Key Competitors

Growth Generators in the AMR Diagnostics Market

• Growth Metrics
• Growth Drivers
• Growth Restraints
• Forecast Considerations
• Revenue Forecast
• Revenue Forecast by Product
• Revenue Forecast by Region
• Revenue Forecast Analysis
• Pricing Trends and Forecast Analysis
• Revenue Share
• Competitor Matrix-Product Portfolio Analysis
• Revenue Share Analysis

Growth Generators for Phenotypic Tests

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region
• Forecast Analysis

Growth Generators for Molecular Tests

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region
• Forecast Analysis

Growth Opportunity Universe

• Growth Opportunity 1: WGS Driving Molecular Tests
• Growth Opportunity 2: Multiplex POCT
• Growth Opportunity 3: Antimicrobial Stewardship Through Private-Public Partnerships

Appendix & Next Steps

• Benefits and Impacts of Growth Opportunities
• Next Steps
• List of Exhibits
• Legal Disclaimer